NCT07647276

Brief Summary

This randomized controlled clinical trial aims to investigate the effects of Connective Tissue Massage (CTM) and music-based Progressive Muscle Relaxation Training (PMRT) on pain intensity, pressure pain threshold, analgesic use, and menstruation-related symptoms in women with primary dysmenorrhea. Participants will be randomly assigned to one of three groups: CTM, music-based PMRT, or control. Baseline assessment will be conducted during menstrual days 1-2 of Cycle 0. The interventions will be applied during the premenstrual intervention window of Cycle 0, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Post-intervention assessment will be conducted during menstrual days 1-2 of Cycle 1. No intervention will be applied after the post-intervention assessment, and follow-up assessment will be conducted during menstrual days 1-2 of Cycle 2. Outcomes including pain intensity, pressure pain threshold, analgesic use, menstrual symptoms, attitudes toward menstruation, functional and emotional impact of dysmenorrhea, and pain catastrophizing will be evaluated across menstrual cycles. Participant satisfaction and adherence to the interventions will also be assessed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Jun 2026Nov 2026

First Submitted

Initial submission to the registry

May 21, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 15, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

June 22, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2026

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

4 months

First QC Date

May 21, 2026

Last Update Submit

June 26, 2026

Conditions

Keywords

Primary dysmenorrheaConnective tissue massageProgressive muscle relaxation trainingPain

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity

    Participants' menstrual pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will be asked to rate the average pain intensity experienced during the first two days of menstruation, the average pain intensity experienced throughout the menstrual period, and the worst pain intensity experienced during menstruation. The VAS is widely used in clinical practice and scientific research to assess pain perception. Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and therefore a worse outcome.

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

Secondary Outcomes (6)

  • Pain Catastrophizing Scale

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

  • Functional and Emotional Dysmenorrhea Scale

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

  • Menstrual Attitude Scale

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

  • Menstrual Symptom Scale

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

  • Pain Threshold

    Cycle 0, menstrual days 1-2; Cycle 1, menstrual days 1-2, approximately Week 4; Cycle 2, menstrual days 1-2, approximately Week 8. Each cycle is expected to last 28 +/- 7 days.

  • +1 more secondary outcomes

Other Outcomes (2)

  • Intervention Satisfaction

    Cycle 1, menstrual days 1-2, approximately Week 4. Each cycle is expected to last 28 +/- 7 days.

  • Intervention Adherence

    From the estimated ovulation day of Cycle 0, calculated as cycle length minus 14 days, until Cycle 1 Day 1, approximately 14 days. Each cycle is expected to last 28 +/- 7 days.

Study Arms (3)

Connective Tissue Massage Group

EXPERIMENTAL

Participants in this group will receive Connective Tissue Massage. The intervention will be applied to the sacrolumbar, lower thoracic, abdominal, and anterior pelvic regions. Sessions will be performed five days per week during the Cycle 0 premenstrual intervention window, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Each session will last approximately 10-15 minutes.

Other: Connective Tissue Massage

Music-Based Progressive Muscle Relaxation Group

EXPERIMENTAL

Participants in this group will receive music-based Progressive Muscle Relaxation Training. Participants will receive face-to-face instruction at the beginning of the study, and the first session will be conducted in person. Thereafter, participants will perform the training using approved audio recordings from the Turkish Psychological Association. Sessions will be performed five days per week during the Cycle 0 premenstrual intervention window, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Each session will last approximately 20-30 minutes.

Other: Music-based Progressive Muscle Relaxation

Control Group

NO INTERVENTION

Participants in the control group will not receive any intervention during the study period. They will be asked not to receive complementary interventions that may reduce menstrual pain or promote relaxation, such as acupuncture, massage, or other mind-body techniques. Participants will continue their routine daily activities without restriction. After completion of the study, participants in the control group will be offered Connective Tissue Massage or music-based Progressive Muscle Relaxation Training according to their preference.

Interventions

Participants will receive music-based Progressive Muscle Relaxation Training (PMRT) using recordings from the Turkish Psychological Association's Relaxation Exercises CD. At the beginning of the study, participants will be informed face-to-face about the purpose, procedure, and breathing techniques of PMRT, and the first session will be conducted in person. Thereafter, PMRT sessions will be performed using the approved audio recordings. The intervention will be performed five days per week during the Cycle 0 premenstrual intervention window, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Each session will last approximately 20-30 minutes.

Music-Based Progressive Muscle Relaxation Group

Connective tissue manipulation will be applied to the sacrolumbar, lower thoracic, abdominal, and anterior pelvic regions. The intervention will be performed five days per week during the Cycle 0 premenstrual intervention window, from the estimated ovulation day, calculated as cycle length minus 14 days, until Cycle 1 Day 1. Each session will last approximately 10-15 minutes.

Connective Tissue Massage Group

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having a diagnosis of primary dysmenorrhea made by a Gynecology and Obstetrics specialist
  • Being between 18-30 years of age
  • Being nulliparous
  • Having a regular menstrual cycle (28 ± 7 days)
  • Having menstrual pain intensity greater than 4 cm on the Visual Analog Scale for the last 6 months
  • Voluntarily agreeing to participate in the study

You may not qualify if:

  • Having been diagnosed at least 6 months prior with gastrointestinal, urogynecological, autoimmune, or psychiatric diseases and/or chronic pain syndromes
  • Having any neurological or systemic disease
  • Having a history of childbirth or previous pregnancy
  • Being pregnant
  • Using an intrauterine device (IUD)
  • Having any pelvic pathology or history of pelvic surgery
  • Chronic use of medications, including oral contraceptives or antidepressants
  • Currently receiving anti-inflammatory, analgesic, or psychotherapeutic drug treatment
  • Having irregular menstrual cycles (\<21 or \>35 days and/or cycle variation \>4 days)
  • Presence of pathology indicating secondary dysmenorrhea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University, Faculty of Physiotherapy and Rehabilitation

Denizli, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor will be blinded to group allocation. Due to the nature of the interventions, participants and intervention providers cannot be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a three-arm, parallel-group, randomized controlled clinical trial. Eligible participants with primary dysmenorrhea will be randomly assigned to one of three groups: Connective Tissue Massage, Music-Based Progressive Muscle Relaxation Training, or Control. Interventions will be delivered over two consecutive intervention menstrual cycles following baseline assessment. No intervention will be delivered before the follow-up assessment, which will be conducted during the first menstrual cycle after cessation of the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 21, 2026

First Posted

June 15, 2026

Study Start

June 22, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

November 15, 2026

Last Updated

June 30, 2026

Record last verified: 2026-06

Locations